OS Therapies CEO Grants 500K Stock Options, Boosting Investor Confidence Amid Clinical Milestone Hopes
OS Therapies CEO grants 500k stock options, signaling confidence and potential upside as the company pushes osteosarcoma milestones; investors weigh dilution vs. growth.
4 minutes to read